$528 Million is the total value of Tygh Capital Management, Inc.'s 84 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CUB | New | CUBIC CORP | $12,496,000 | – | 214,815 | +100.0% | 2.37% | – |
| SILK | New | SILK ROAD MEDICAL INC | $9,208,000 | – | 137,010 | +100.0% | 1.74% | – |
| VERX | New | VERTEX INC CLASS A | $7,723,000 | – | 335,778 | +100.0% | 1.46% | – |
| PRSC | New | PROVIDENCE SERVICE CORPORATION | $6,246,000 | – | 67,223 | +100.0% | 1.18% | – |
| PGNY | New | PROGYNY INC | $5,654,000 | – | 192,100 | +100.0% | 1.07% | – |
| CVLT | New | COMMVAULT SYSTEMS INC | $5,280,000 | – | 129,405 | +100.0% | 1.00% | – |
| SHYF | New | SHYFT GROUP INC | $4,618,000 | – | 244,582 | +100.0% | 0.88% | – |
| OLLI | New | OLLIE'S BARGAIN OUTLET HOLDING | $3,917,000 | – | 44,842 | +100.0% | 0.74% | – |
| CVLG | New | COVENANT LOGISTICS GROUP INC C | $3,903,000 | – | 223,184 | +100.0% | 0.74% | – |
| HCI | New | HCI GROUP INC | $3,736,000 | – | 75,790 | +100.0% | 0.71% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $3,633,000 | – | 21,877 | +100.0% | 0.69% | – |
| RVLV | New | REVOLVE GROUP INC CLASS A | $3,443,000 | – | 209,538 | +100.0% | 0.65% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $2,996,000 | – | 32,322 | +100.0% | 0.57% | – |
| PLNT | New | PLANET FITNESS INC CLASS A | $2,695,000 | – | 43,742 | +100.0% | 0.51% | – |
| WGO | New | WINNEBAGO INDUSTRIES | $2,675,000 | – | 51,767 | +100.0% | 0.51% | – |
| LCII | New | LCI INDUSTRIES | $2,646,000 | – | 24,895 | +100.0% | 0.50% | – |
| LMND | New | LEMONADE INC | $2,638,000 | – | 53,066 | +100.0% | 0.50% | – |
| NVTA | New | INVITAE CORP | $2,587,000 | – | 59,672 | +100.0% | 0.49% | – |
| OSUR | New | ORASURE TECHNOLOGIES INC | $2,496,000 | – | 205,101 | +100.0% | 0.47% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL INC | $2,410,000 | – | 29,323 | +100.0% | 0.46% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INC | $2,400,000 | – | 55,726 | +100.0% | 0.46% | – |
| FGEN | New | FIBROGEN INC | $1,978,000 | – | 48,106 | +100.0% | 0.38% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $1,900,000 | – | 72,304 | +100.0% | 0.36% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $1,830,000 | – | 129,581 | +100.0% | 0.35% | – |
| BHVN | New | BIOHAVEN PHARMACEUTICAL HOLDIN | $1,776,000 | – | 27,325 | +100.0% | 0.34% | – |
| PTCT | New | PTC THERAPEUTICS INC | $1,720,000 | – | 36,792 | +100.0% | 0.33% | – |
| IOSP | New | INNOSPEC INC | $1,372,000 | – | 21,660 | +100.0% | 0.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-05
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUANTA SERVICES INC | 28 | Q4 2021 | 1.9% |
| ICON PLC | 27 | Q4 2021 | 3.1% |
| MASTEC INC | 24 | Q4 2019 | 3.0% |
| SPDR S&P BIOTECH ETF | 24 | Q4 2021 | 1.8% |
| NICE SYSTEMS LTD SPONS ADR | 23 | Q4 2020 | 2.4% |
| H&E EQUIPMENT SERVICES INC | 23 | Q4 2021 | 2.9% |
| LITTELFUSE INC | 23 | Q4 2021 | 2.0% |
| KINSALE CAPITAL GROUP INC | 22 | Q4 2021 | 4.1% |
| TOWER SEMICONDUCTOR LTD | 22 | Q4 2021 | 3.2% |
| WESTERN ALLIANCE BANCORP | 22 | Q4 2021 | 3.2% |
View Tygh Capital Management, Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SUN HEALTHCARE GROUP INC | February 09, 2010 | 4 | 4.0% |
| SUPERTEX INC | February 10, 2009 | 4 | 4.0% |
| LADISH CO INC | February 07, 2008 | 4 | 4.0% |
| NOVATEL INC | February 07, 2008 | 4 | 4.0% |
View Tygh Capital Management, Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-02 |
| 13F-HR | 2021-08-11 |
| 13F-HR | 2021-05-10 |
| 13F-HR | 2021-02-08 |
| 13F-HR | 2020-11-05 |
| 13F-HR | 2020-08-05 |
| 13F-HR | 2020-04-29 |
| 13F-HR | 2020-02-04 |
| 13F-HR | 2019-11-05 |
View Tygh Capital Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.